New research out of VCU Massey Cancer Center points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer. Recently published in Cell Reports, the findings could ...
Nov 30, 2022
0
53
Cholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers and approximately 3% of gastrointestinal tumors. While rare, the ...
Nov 29, 2022
0
25
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of targeted approach a "prodrug"—a medicine designed ...
Nov 16, 2022
0
1583
A study of 11,945 people in six European countries has shown that people with type 2 diabetes who develop cancer are more likely to be diagnosed with advanced disease if the condition is one that is not screened for routinely.
Nov 16, 2022
0
30
Cribriform prostate cancer is an aggressive subtype of the disease characterized by its histology, but little is known about its molecular pathways. Research from Vanderbilt-Ingram Cancer Center has revealed new information ...
Oct 27, 2022
0
66
Breast cancer is the most common cancer in the world. Every year it claims more than 650,000 lives.
Oct 20, 2022
0
27
Cancer is an umbrella term for diseases characterized by the uncontrollable growth of tumor cells. Often, these tumor cells invade and colonize adjoining organs, giving rise to what is clinically referred to as metastasis.
Oct 19, 2022
0
41
Gastric cancer is a common malignant tumor that originates from the gastric mucosal epithelium. Being insidious and non-specific, the early-stage symptoms of the cancer are similar to that of chronic diseases such as gastritis ...
Sep 28, 2022
0
1
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
Sep 23, 2022
0
3410
In a recent University of Kentucky Markey Cancer Center clinical trial, patients with advanced cancer experienced improved outcomes when their treatments were directed by a molecular tumor board.
Sep 22, 2022
0
18
